GRemHAp
Hepatic Diseases in Primary Care Research Group
The Group of Hepatic Diseases in Primary Care belonging to the Metropolitan North USR of the Barcelona province was formed in 2005, being a group consolidated by IDIAP Jordi Gol and linked to the Center for Biomedical Research in the Network of Diseases Hepatic and Digestive (CIBEREHD). At the moment it is constituted by a stable group of researchers, made up of 7 doctors, a research technician, 4 nurses and a pharmacist. So far it has been characterized by the development of population studies in primary care. One of them included a total of 766 subjects being the basis of the first and only study on the prevalence of non-alcoholic fatty liver carried out in our country. Another study finalized recently with a total of 3076 subjects on the early detection of liver fibrosis in the general population. Study that has aroused much interest in the results obtained. We are currently tracking this cohort.
Group projects
|
PI: Caballería Rovira, Llorenç. Screening for liver fibrosis - population-based study across European countries. Funding: Fundació Clínic per a la Recerca Biomèdica. Duration: 2020 - 2024 |
|
PI: Martínez Escudé, Alba. Cribado poblacional de fibrosis hepática con elastografia transitoria en personas con factores de riesgo de enfermedad hepática e índice de grasa hepática elevado. Estudio de validación. Funding: Instituto de Salud Carlos III. Duration: 2019 - 2021 |
The group participates in the following publications
|
Graupera I, Thiele M, Serra-Burriel M, Caballeria L, Roulot D, Wong GL, Fabrellas N, Guha IN, Arslanow A, Expósito C, Hernández R, Aithal GP, Galle PR, Pera G, Wong VW, Lammert F, Ginès P, Castera L, Krag A; Investigators of the LiverScreen Consortium. Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the Population. Clin Gastroenterol Hepatol. 2021 Dec; doi:10.1016/j.cgh.2021.12.034. Epub 2021 Dec 29. PMID:34971806. IF: 11,382. |
|
Julián MT, Pera G, Soldevila B, Caballería L, Julve J, Puig-Jové C, Morillas R, Torán P, Expósito C, Puig-Domingo M, Castelblanco E, Franch-Nadal J, Cusi K, Mauricio D, Alonso N. Atherogenic dyslipidemia, but not hyperglycemia, is an independent factor associated with liver fibrosis in subjects with type 2 diabetes and NAFLD: a population-based study. Eur J Endocrinol. 2021 Apr; 184(4):587-596. doi:10.1530/EJE-20-1240. PMID:33606661. IF: 6,664. |
|
Martínez-Escudé A, Pera G, Costa-Garrido A, Rodríguez L, Arteaga I, Expósito-Martínez C, Torán-Monserrat P, Caballería L. TSH Levels as an Independent Risk Factor for NAFLD and Liver Fibrosis in the General Population. J Clin Med. 2021 Jun; 10(13). doi:10.3390/jcm10132907. Epub 2021 Jun 29. pmc:PMC8267939. PMID:34209831. IF: 3,303. |
|
Martínez-Escudé A, Pera G, Rodríguez L, Arteaga I, Expósito-Martínez C, Torán-Monserrat P, Caballería L. Risk of Liver Fibrosis According to TSH Levels in Euthyroid Subjects. J Clin Med. 2021 Mar; 10(7). doi:10.3390/jcm10071350. Epub 2021 Mar 25. pmc:PMC8037170. PMID:33805893. IF: 3,303. |
|
Massot Mesquida M, de la Fuente JA, Andrés Lorca AM, Arteaga Pillasagua I, Balboa Blanco E, Gracia Vidal S, Pablo Reyes S, Gómez Iparraguirre P, Seda Gombau G, Torán-Monserrat P. Primary Care Records of Chronic-Disease Patient Adherence to Treatment. Int J Environ Res Public Health. 2021 Apr; 18(7). doi:10.3390/ijerph18073710. Epub 2021 Apr 02. pmc:PMC8037733. PMID:33918156. IF: 2,849. |
|
Pose E, Pera G, Torán P, Gratacós-Ginès J, Avitabile E, Expósito C, Díaz A, Graupera I, Rubio AB, Ginès P, Fabrellas N, Caballeria L. Interaction between metabolic syndrome and alcohol consumption, risk factors of liver fibrosis: A population-based study. Liver Int. 2021 07; 41(7):1556-1564. doi:10.1111/liv.14830. Epub 2021 Mar 11. PMID:33595176. IF: 5,828. |
Indicators
|
Indicator |
2021 |
|---|---|
|
Researchers with PhD |
6 |
|
Total number of projects in which group members have participated |
2 |
|
Total number of projects in which the PI of the project has belonged to the group |
2 |
|
Total Funding |
321.730 € |
|
Scientific publications in indexed journals |
6 |
|
Total Impact factor |
33,33 |
|
Nº of articles in Q1 journals |
2 |
|
Q1 IF |
18,046 |
|
Nº of articles in Q2 journals |
1 |
|
Q2 IF |
5,828 |
